apoptosis 
 
?? ????? 
 
     ??????????????????????????????
?????????(neurodegenerative disease)??????????????
???????????????????????????????????
?(Alzheimer’s disease??? AD)??????(Parkinson’s disease)??????
(Huntington’s disease)???????????(amyotrophic lateral sclerosis)??
???????????????????AD??????????????
???????????????????????????????????
???????????????????????????? AD?????
???????????????????????????????????
?????????? AD?????????? 
????????????????????(Reactive oxygen species?
ROS)????????????????????????????????
??????????????????? ROS?????????????
????????? AD???????????????? AD??????
???????????????<1>??????????????????
??? Fe?Al?Cu?????<2>???????????????????
??????? 4-hydroxynonenal (4-HNE)??????4-HNE???????
?????? DNA?RNA???????????????????? Ca2+?
????????????<3>????????????????(carbonyl 
compound)? DNA???? 8-Hydroxyguanosine(8-OHG)????? DNA??
????????<4>???? Cytochrome c oxidase????????????
????? ROS???????????????<5>AD?????????
?????????(amyloid plaques)??????????????????
? β?????(βamyloid plaques?Aβ)??????????????Aβ??
?????(aggregation)??????? β-sheet??????????????
???????????????????????????????????
?????? synaptosomal membrane systems??????????????
???????????????????????????????????
?????????????????(vanilic acid, cinnamic acid, coumaric acid)
????????????? synaptosomal membrane systems????????
???Yan??(2001)????????? amyloid peptide Aβ1-42???????
??????????????????? 0.006%????????????
28?????????????????????? Aβ??????????
???????????? Aβ??????????????????? AD
?????????? 
    ?????????????????????????????????
???????????? Aβ?????????????????????
??? Aβ25-35???????????????????????????
Aβ25-35?????????????????? 
 
?? ????? 
 
1.  Aβ25-35??????? Neuro-2A??????? 
  ????? Aβ25-35???????? Neuro-2A??? Aβ25-35? Neuro-2A
?????(LD50)??? 1????????(0.1?1?10?15? 20 µM)? Aβ25-35
?? Neuro-2A????? Aβ25-35????????????????????
???????????????? Aβ25-35???????????????
?????????????????? Neuro-2A??????(LD50)? 14.9 
µM????????? Aβ25-35????? 20 µM?????? 15 µM????
???????????????? 15 µM? Aβ25-35???????????
?? 
 
2.  ?????? Aβ25-35???????? Neuro-2A????? 
  ???????????????????????????????
???????????????????? Aβ25-35???????????
??? TBARS????????????????????????????
???????(Thiobarbituric acid; TBA)????????????????
(malonaldehyde)? TBA?????? 532 nm??????????Neuro 2A?
?? Aβ25-35?? 24??????????????????????????
??(50~200µg/mL)?????????????(p<0.05) (? 4)???????
???? 500 µg/mL??????????????????????????
???????????????????????????????????
??????????? 
 
5.  ?????肽(glutathione)????? 
      ???肽 ??????????????????????????
???????????????肽???????????????????
????????????????肽?????????????????
??????? CMF-DA??????????????????肽????
???????? Aβ25-35??????? GSH???????Aβ?? 1??
??GSH????????? 79%(? 5A)??? 200µg/mL????????
?????? GSH??????????(? 5B)? 
 
6.  ????????? 
      ??????????????????????????????
Rhodamine 123???????????????????????????
??? Aβ25-35??????????????????? 4????????
??????? 66%(? 6A)??????????????????????
????????????????????????? 200 µg/mL?????
???????????(105%; ? 6B)? 
 
7.  ???????? 
      ??????????(Type II Program Cell Death)?????(autophagy)
??????????????(Autophagic vacuoles; AVs)????????
Neuro 2A? Aβ25-35?? 48????????????????? 7A????
 ?????? 
1. Yankner, B. A. Mechanisms of neuronal degeneration in Alzheimer’s disease. 
Neuron 1996, 16, 921-932. 
2.  Lockshin, R. A.; Zakeri, Z. Apoptosis, autophagy, and more. Int. J. Biochem. Cell 
Biol. 2004, 36, 2405-2419. 
3.  Anglade, P.; Vyas, S.; Javoy-Agid, F.; Herrero, M. T.; Michel, P. P.; Marquez, J.; 
Mouatt-Prigent, A.; Ruberg, M.; Hirsch, E. C.; Agid, Y. Apoptosis and autophagy 
in nigral neurons of patients with Parkinson’s disease. Histol. Histopathol. 1997 
12(1) 25-31. 
3.  Bras, M.; Queenan, B.; Susin, S. A. Programmed cell death via mitochondria: 
different modes of dying. Biochem. (Mosc) 2005, 70, 231-239. 
4.  Cohen, I.; Castedo, M.; kroemer, G. Tantalizing thanatos: unexpected links in 
death pathways. Trends. Cell Biol. 2002, 12, 293-295. 
5.  Ou S, Kwok KC. Review?Ferulic acid?Pharmaceutical functions, preparation and 
applications in foods. J. Sci. Food Agric. 2004, 84?1261-1269. 
6.  Yan, J. J.; Cho, J. Y.; Kim, H. S.; Kim, K. L.; Jung, J. S.; Huh, S. O.; Suh, H. W.; 
Kim, Y. H.; Song, D. K. Protection against β-amyloid peptide toxicity in vivo with 
long-term administration of ferulic acid. Brit. J. pharmaco. 2001, 133, 89-96. 
7.  ????1996???-?????????????12(3)?94-102? 
8.  Schulz, J. B.; Lindenau, J.; Seyfried, J.; Dichgans, J. Glutathione, oxidative stress 
and neurodegeneration. Eur J Biochem 2000, 267: 4904-4911 
9.  Marchetti, P.; Castedo, M.; Susin, S.A.; Zamzami, N.; Hirsch, T.; Macho, A.; 
Haeffner, A. Mitochondrial permeability transition is a central coordinating event 
of apoptosis. J. Exp. Med. 1996, 184: 1155-1160 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2A A. sinensis extracts protected mouse Neuro2A cells from Aβ-induced 
neurotoxicity. Treatment of mouse Neuro-2A cells with the toxic fragment of fibril 
Aβ25-35 for 48 hr decreased cell viability was measured by MTT assay. A. sinensis 
extracts reduced the Aβ-induced neurotoxicity. * p< 0.0001, # p> 0.01. (compare with 
control). ASW: water extraction; ASalc: Alcohol extraction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2B 
Extraction time (min)
15 30 60 90
V
ia
bi
lit
y 
(%
 o
f c
on
tr
ol
) 
0
20
40
60
80
100
120
ASW+AB
control
ASalc+AB
15uM AB
*
# #
#
# #
#
# #
A
AS extract (µg/ml)
0 25 50 100 200 300
V
ia
bi
lit
y 
(%
)
0
20
40
60
80
100
Aβ treated
Aβ/ASext treated
  
  *
     *
         
B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3A 
Time (min)
0 20 40 60 80 100 120 140
D
C
F 
flu
or
es
ce
nc
e 
(%
 o
f c
on
tro
l)
0
20
40
60
80
100
120
140
160
180
Aβ treated
#
 #
Aβ 
control 
A 
 AS extract (µg/ml)
0 50 100 200 
TB
A
R
S 
 (%
 o
f c
on
tro
l)
0
20
40
60
80
100
120
Aβ treatment
Aβ/AS extract
    *     *
    *
 
 
 
 
Figure 4. Effect of AS extract against Aβ-induced TBARS formation. Neuro 2A cells 
were exposed to Aβ (15 µM) in the presence and absence of AS extract (50, 100 and 
200 µg/ml). The values represent mean ? SD. * p<0.05 compared with control. 
Time (hr)
control 0.5 1 2 4 
Fl
uo
re
sc
en
ce
 (%
 o
f c
on
tro
l)
0
20
40
60
80
100
120
140
Control
Aβ treated    *
* *
     *
 * *
   A
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6A 
 
 
Control 
0.5 h Aβ treated 
1 h Aβ treated 
2 h Aβ treated 
4 h Aβ treated 
